Grant: Applied Research and Development Grants - Level 1

Pfizer Canada Inc. is a Canadian company incorporated in April 2004 that manufactures and markets pharmaceutical products. In order to grow and innovate in the development and manufacture of drugs and vaccines, Pfizer Canada wants to develop a system for tracking pharmaceutical vials from the manufacturing lines to the products available on the sales counters. This development requires the development of a high-capacity, already programmed RFID 4.0 labelling device, adaptable to small 1cm x 2cm glass vials (about 10,000,000 products annually), at a cost of less than $0.15 per label, with a fixed dual-antenna RFID reader for detecting inventory entries and rejects at a cost of less than $5,000 per reader. This system, which makes it possible to control and ensure the individual traceability of vaccine vials, from manufacture to distribution, will also have to integrate the data collected into the company's proprietary software platform. To do this, Pfizer Canada is seeking C2T3's expertise in wireless telecommunications and RFID to determine possible solutions for the development of this innovative device. For Pfizer Canada, this project is an important vehicle for innovation to develop the company's best practices in accordance with FDA, Health Canada and Industry 4.0 standards for this business line.